-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Antidepressants for Depression in Dementia (HTA-SADD)
Recent Elderly Mental Health-Related Systematic Reviews and Meta-Analyses
Some of the following articles may be available freely where indicated (depending on local circumstances). Access to the full-text of the other articles will require a suitable Athens password, a journal subscription or payment. The Bibliographic Citations Leong, C. (2014). … Continue reading →
Posted in Depression, For Doctors (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Pharmacological Treatments, Systematic Reviews
|
Tagged Agitation, Antidepressants, Antidepressants for Depression in Dementia, Antidepressants for Depression in Dementia (HTA-SADD), Anxiety, Apathy, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, C9orf72, Dextromethorphan / Quinidine (DM/Q: Nuedexta™), Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V), Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV), Dronabinol, DSM-5, Frontotemporal Dementia, GRN, Impulse Control Disorder, Neurocognitive Disorders, Neuropsychiatric Symptoms in Alzheimer’s Disease, Non-Motor Fluctuations in Parkinson's Disease, Pick’s Disease (Frontotemporal Dementia), Pseudobulbar Affect (PBA), Psychological Symptoms of Dementia (BPSD), Psychosis in Frontotemporal Dementia, Sleep Disturbances, Visual Hallucinations
|
Leave a comment
Sertraline or Mirtazapine Versus a Placebo for Treatment of Depression in Dementia (HTA-SADD Trial)
Summary This randomised control trial took place across nine English old-age psychiatry units. It examined the clinical effectiveness of sertraline and mirtazapine in reducing depression compared with a placebo. 326 patients with Alzheimer’s Disease (AD), depression and a Cornell Scale … Continue reading →
Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), Management of Condition, Mental Health, National, NHS, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest
|
Tagged Alzheimer's Society, Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brighton and Sussex Medical School: University of Sussex, Burden of Dementia, Burden on Caregivers, Caregiving (Carers), Carers, Cornell Scale for Depression in Dementia (CSDD), Dementia Quality of Life (DEMQOL), DEMQOL-Proxy, Department of Community Based Medicine, Department of Mental Health Sciences: University College London, Department of Psychiatry: Liverpool University, Department of Psychiatry: University of Birmingham, Department of Psychiatry: University of Cambridge, Department of Psychiatry: University of Leicester, Department of Psychiatry: University of Southampton, Depression / Dysphoria, Depression in Alzheimer’s Disease Study-II (DIADS)-II, Depression in Dementia, Family Caregivers, Health Services and Population Research Department: King’s College London, Health Technology Assessment Study, HTA-SADD Trial, Hull York Medical School, Institute for Ageing and Health: Newcastle University, Institute of Psychiatry: King's College London, Institute of Rehabilitation: Hull York Medical School, Kings College London, Lancet, Liverpool University, Local Research Ethics Approvals (LREC), Mental Health and Neuroscience Clinical Trials Unit: King’s College London, Mirtazapine, Newcastle University, NIHR Health Technology Assessment Programme, Professor Sube Banerjee, Psychological Symptoms of Dementia (BPSD), Sertraline, Study of Antidepressants for Depression in Dementia (SADD), UK National Institute of Health Research HTA Programme, University College London, University of Birmingham, University of Cambridge, University of East Anglia, University of Leicester, University of Manchester, University of Southampton, University of Sussex, Venlafaxine, Watchful Waiting, Wolfson Centre for Age-Related Disease: King’s College London
|
Leave a comment
Discontinuation of Antidepressants in People with Dementia and Neuropsychiatric Symptoms (DESEP Study) (BMJ)
[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 9, April 2012]. Summary Roughly 80% of nursing home residents have dementia in Norway. 90% have neuropsychiatric symptoms. Roughly 40% of residents in Norwegian … Continue reading →
Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments
|
Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Buddhist Tzu Chi University (Hualien Taiwan), Centre for Old Age Psychiatric Research (Innlandet Hospital Trust), Citalopram, Clinical Dementia Rating Scale, College of Medical Science and Technology: Taipei Medical University, Cornell Scale for Depression in Dementia (CSDD), Department of Dermatology: Wan Fang Hospital, Department of Emergency: Min-Sheng General Hospital, Department of Surgery: Buddhist Tzu Chi University, Depression / Dysphoria, Depression in Older People, Depressive Symptoms, DESEP Study, Escitalopram, Graduate Institute of Biomedical Informatics: Taipei Medical University, Innlandet Hospital Trust (Ottestad; Norway), International Center for Health Information Technology (ICHIT): Taipei Medical University, Lawton and Brody’s Physical Self Maintenance Scale, Min-Sheng General Hospital (Taoyuan City Taiwan), Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory Scale, Neuropsychiatric Inventory-Nursing Home version (NPI-NH), Neuropsychiatric Symptoms, Norway, Norwegian Centre for Dementia Research, Nursing Home Residents with Dementia, Nursing Home Residents with Dementia (in Norway), Nursing Homes, Paroxetine, Quality of Life-Alzheimer’s Disease Scale, School of Medicine: Buddhist Tzu Chi University, Selective Serotonin Reuptake Inhibitors (SSRIs), Sertraline, Severe Impairment Battery, SSRIs: Selective Serotonin Reuptake Inhibitors, Systematic Reviews and Meta-Analyses, Taipei Medical University, Taiwan, TMU Research Center of Cancer Translational Medicine (Taipei Taiwan), Unified Parkinson’s Disease Rating Scale, University Hospital (Oslo), Wan Fang Hospital (Taipei Taiwan)
|
Leave a comment
Evidence Update: Treatment of Depression in People With Dementia (NHS Evidence)
Summary Depression is common in dementia. It often causes distress, reduces quality of life, worsens cognitive and functional impairment, increases mortality, and also brings about stress and depression in carers. Earlier Guidance The NICE Clinical Guideline on Dementia (CG42) recommends … Continue reading →
Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), Guidelines, Management of Condition, National, NHS Evidence, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Systematic Reviews, UK, Universal Interest
|
Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Depression / Dysphoria, Depression in Older People, Mirtazapine, National Institute for Health and Clinical Excellence (NICE), NICE, NICE Clinical Guideline CG90, NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Professor Sube Banerjee, Sertraline
|
Leave a comment
Health Technology Assessment Study into the Use of Antidepressants for Depression in Dementia (HTA-SADD)
[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 1, August 2011]. Summary Research into the efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, has found that these treatments … Continue reading →
Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), In the News, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest
|
Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Cornell Scale for Depression in Dementia (CSDD), Depression / Dysphoria, Health Technology Assessment Study, Mirtazapine, Sertraline, UK National Institute of Health Research HTA Programme
|
Leave a comment
